SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-096651
Filing Date
2023-12-19
Accepted
2023-12-19 08:00:53
Documents
155
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0923_bimiinter.htm   iXBRL 10-Q 1364799
2 CERTIFICATION f10q0923ex31-1_bimiinter.htm EX-31.1 9832
3 CERTIFICATION f10q0923ex31-2_bimiinter.htm EX-31.2 9906
4 CERTIFICATION f10q0923ex32-1_bimiinter.htm EX-32.1 3850
5 CERTIFICATION f10q0923ex32-2_bimiinter.htm EX-32.2 3921
  Complete submission text file 0001213900-23-096651.txt   11290161

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bimi-20230930.xsd EX-101.SCH 174301
7 XBRL CALCULATION FILE bimi-20230930_cal.xml EX-101.CAL 93160
8 XBRL DEFINITION FILE bimi-20230930_def.xml EX-101.DEF 671090
9 XBRL LABEL FILE bimi-20230930_lab.xml EX-101.LAB 1061914
10 XBRL PRESENTATION FILE bimi-20230930_pre.xml EX-101.PRE 689991
149 EXTRACTED XBRL INSTANCE DOCUMENT f10q0923_bimiinter_htm.xml XML 1292527
Mailing Address 725 5TH AVENUE, 15TH FLOOR, 15-01 NEW YORK NY NEW YORK
Business Address 725 5TH AVENUE, 15TH FLOOR, 15-01 NEW YORK NY NEW YORK 212-542-0028
BIMI International Medical Inc. (Filer) CIK: 0001213660 (see all company filings)

IRS No.: 020563302 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34890 | Film No.: 231495661
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries
(CF Office: 07 Trade & Services)